Matinas BioPharma Holdings Cash Flow 2011-2024 | MTNB

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Operating Cash Flow	-15.3 M	-19.2 M	-15.2 M	-17.4 M	-14.1 M	-10.3 M	-11.5 M	-6.12 M	-7.81 M	-	-	-	-
Depreciation & Amortization	385 K	337 K	244 K	231 K	206 K	218 K	101 K	52.6 K	43.5 K	41.6 K	1.13 K	-	-
Accounts Payables	514 K	618 K	937 K	350 K	679 K	296 K	583 K	476 K	498 K	271 K	-	-	-
Accounts Receivables	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Inventories	-	-	-	-	-	-	-	-	-	-	-	-	-

	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Operating Cash Flow	-	-	-4.09 M	-	-14.9 M	-9.89 M	-4.76 M	-	-11.3 M	-5.52 M	-4.65 M	-	-13.1 M	-7.83 M	-4.66 M	-	-9.19 M	-5.12 M	-3.02 M	-	-7.7 M	-5.06 M	-2.81 M	-	-9.54 M	-6.76 M	-3.03 M	-	-4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	98 K	97 K	93 K	-	89 K	86 K	69 K	-	179 K	117 K	58.6 K	-	173 K	115 K	57.6 K	-	149 K	96.9 K	47.9 K	-	157 K	100 K	47.1 K	-	56.2 K	12 K	12 K	-	40 K	13 K	12.9 K	-	32.7 K	20.6 K	10.9 K	-	51.5 K	19.9 K	9.45 K	-	662	3.58 K	-	-	-	-	-	-	-	-	-
Accounts Payables	835 K	604 K	516 K	618 K	657 K	497 K	1.35 M	938 K	662 K	450 K	422 K	350 K	350 K	350 K	350 K	679 K	679 K	679 K	679 K	296 K	296 K	296 K	296 K	583 K	583 K	583 K	583 K	476 K	476 K	476 K	476 K	498 K	498 K	498 K	498 K	271 K	271 K	271 K	271 K	397 K	397 K	397 K	397 K	-	-	-	-	-	-	-	-
Accounts Receivables	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	89.8 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Inventories	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-